Effect of post-discontinuation therapy (PDT) on survival in metastatic gastric-gastroesophageal junction (G-GEJ) adenocarcinoma patients from the RAINFALL trial: An exploratory analysis.

Kohei Shitara,Manish A. Shah,Maria Di Bartolomeo,Sara Lonardi,Salah-Eddin Al-Batran,Eric Van Cutsem,David H. Ilson,Ian Chau,Maria Alsina,Jill Lacy,Daisuke Takahari,Naotoshi Sugimoto,Johanna C. Bendell,Zev A. Wainberg,Mustapha Tehfe,David Ferry,Ran Wei,Richard A. Walgren,Mayukh Das,Charles S. Fuchs

Effect of post-discontinuation therapy (PDT) on survival in metastatic gastric-gastroesophageal junction (G-GEJ) adenocarcinoma patients from the RAINFALL trial: An exploratory analysis.

2018

4044Background: The global, randomized, placebo (PL)-controlled phase 3 RAINFALL trial evaluated if addition of ramucirumab (RAM) to first-line (1L) cisplatin plus fluoropyrimidine (chemo) improved...

Keywords:

Gastroesophageal Junction
Discontinuation
Gastroenterology
Pathology
Internal medicine
Adenocarcinoma
Medicine
exploratory analysis
Ramucirumab
Placebo
Cisplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations